Krisztian Nagy is a medical doctor (Univ. Pecs/Hungary) and holds an MSc in Public Health from the London School of Hygiene and Tropical Medicine. He has extensive experience with epidemiology and pharmaceutical drug development, worked earlier as head of the Clinical Research Department at Gedeon Richter Plc. Krisztian Nagy was involved in all stages of drug development, supported early preclinical development and supervised clinical projects from phase 1 up to phase 4. He contributed to the development of several new chemical entities, including one recently approved by the FDA in the US, but also to high number of generic and added value pharmaceutical products. He participated and presented at several Scientific Advice meetings at regulatory authorities including the EMA and FDA. He has strong experience in working in international project teams.

He has extensive experience with epidemiology and pharmaceutical drug development, worked earlier as head of the Clinical Research Department at Gedeon Richter Plc. Krisztian Nagy was involved in all stages of drug development, supported early preclinical development and supervised clinical projects from phase 1 up to phase 4.